See also this year's filing and all EDGAR filings for this company.
PDF Report 0001260990_2018_Oncternal_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001260990')"} |
Graph
Absolute values for 0001260990, Oncternal Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 46,077,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 108,000 |
2 | PropertyPlantAndEquipmentNet | 51,000 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 7,975,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 9,188,000 |
9 | ResearchAndDevelopmentExpense | 21,467,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 216,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 46,236,000 |
1 | Liabilities | 7,975,000 |
2 | Expenses | 30,655,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 38,261,000 |
5 | NetIncome | -30,439,000 |
6 | ComprehensiveNetIncome | -30,439,000 |
7 | BaseVar | 42,541,000 |
8 | EconomicCapitalRatio | 1.30 |